The PE ratio for Laboratory Corp Of America Holdings stock stands at 22.4 as of Jun 22, 2026. This takes into account the latest EPS of $11.36 and stock price of $254.43. A decrease of 14% has been observed in the PE ratio compared to its average of 26.0 of the last four quarters.
Over the last ten years, the average PE ratio of Laboratory Corp Of America Holdings has been 22.06. The current 22.4 P/E ratio is similar to the historical average. Looking back at the last ten years, LH's PE ratio peaked in the Dec 2023 quarter at 47.35, with a price of $227.29 and an EPS of $4.8. The Jun 2021 quarter marked the lowest point at 9.34, with a price of $275.85 and an EPS of $29.54.
Maximum annual increase: 182.52% in 2023
Maximum annual decrease: -45.51% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 23.8 | -7.75% | $250.88 | $10.54 |
| 2024 | 25.8 | -45.51% | $229.32 | $8.89 |
| 2023 | 47.35 | 182.52% | $227.29 | $4.8 |
| 2022 | 16.76 | 31.25% | $235.48 | $14.05 |
| 2021 | 12.77 | 0.31% | $314.21 | $24.6 |
| 2020 | 12.73 | -36.64% | $203.55 | $15.99 |
| 2019 | 20.09 | 38.46% | $169.17 | $8.42 |
| 2018 | 14.51 | 9.1% | $126.36 | $8.71 |
| 2017 | 13.3 | -28.11% | $159.51 | $11.99 |
| 2016 | 18.5 | -33.72% | $128.38 | $6.94 |
| 2015 | 27.91 | 56.01% | $123.64 | $4.43 |
| 2014 | 17.89 | 24.5% | $107.9 | $6.03 |
| 2013 | 14.37 | 1.05% | $91.37 | $6.36 |
| 2012 | 14.22 | -13.97% | $86.62 | $6.09 |
| 2011 | 16.53 | 1.91% | $85.97 | $5.2 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 23.49 | -1.3% | $266.81 | $11.36 |
| Dec 2025 | 23.8 | -15.03% | $250.88 | $10.54 |
| Sep 2025 | 28.01 | -2.57% | $287.06 | $10.25 |
| Jun 2025 | 28.75 | 7.72% | $262.51 | $9.13 |
| Mar 2025 | 26.69 | 3.45% | $232.74 | $8.72 |
| Dec 2024 | 25.8 | -38.7% | $229.32 | $8.89 |
| Sep 2024 | 42.09 | 11.88% | $223.48 | $5.31 |
| Jun 2024 | 37.62 | -12.18% | $203.51 | $5.41 |
| Mar 2024 | 42.84 | -9.52% | $218.46 | $5.1 |
| Dec 2023 | 47.35 | 79.49% | $227.29 | $4.8 |
| Sep 2023 | 26.38 | 2.85% | $201.05 | $7.62 |
| Jun 2023 | 25.65 | 24.88% | $241.33 | $9.41 |
| Mar 2023 | 20.54 | 22.55% | $229.42 | $11.17 |
| Dec 2022 | 16.76 | 54.47% | $235.48 | $14.05 |
| Sep 2022 | 10.85 | -2.43% | $204.81 | $18.88 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, LH's PE ratio is higher than the 10-year average, but it is lower than its 3 and 5-year averages.
Laboratory Corp Of America Holdings's price to earnings (P/E) of 22.4 is lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 24.1, Laboratory Corp Of America Holdings's price to earnings (P/E) is 7% lower.
In comparison to its peer IDXX, LH's PE ratio is lower, but it is higher than DGX's and QGEN's.
| Stock name | PE ratio | Market cap |
|---|---|---|
| QGEN Qiagen NV | 19.83 | $7.67B |
| DGX Quest Diagnostics Inc | 21.46 | $21.78B |
| LH Laboratory Corp Of America Holdings | 22.87 | $21.31B |
| IDXX Idexx Laboratories Inc | 39.58 | $42.78B |
| NEO Neogenomics Inc | N/A | $1.48B |
As of Jun 22, 2026, LH stock has a price to earnings ratio of 22.4.
The 3-year average price to earnings ratio for LH stock is 31.54.
The 5-year average price to earnings ratio for LH stock is 24.09.
Over the last ten years, the quarterly PE ratio reached its highest level at 47.35 in the Dec 2023 quarter.
LH's price to earnings ratio is currently 1.5% above its 10-year historical average.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Jun 22, 2026), Laboratory Corp Of America Holdings's share price is $254.43. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $11.36. Therefore, Laboratory Corp Of America Holdings's PE ratio for today is 22.4. PE RATIO(22.4) = STOCK PRICE($254.43) / TTM EPS($11.36)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.